Promising Research For Alzheimer's Disease Cure

There are scientific advancements that lookNational Institute on Aging (NIA), one of the National
promising for controlling and preventing the onset ofInstitutes of Health (NIH).
Alzheimer's disease. Alzheimer's is such a complexAlzhemed is being developed by Neurochem Inc. This
disease that most experts anticipate that a drug thatcompany is just months away from finding out if the
will control the disease will very likely contain a drugdrug developed by their Quebec-based company can
cocktail. The treatment that is only conjecture mayactually slow the course of Alzheimer's disease. A
include a regimen of drugs that is used to treat AIDS.clinical trial of the drug will wrap up in January, with
The progress in the search for a cure for Alzheimer'sresults expected in the spring.
looks promising. Several Research scientists are beingThe company has been developing the drug for over
funded by The Alzheimer's Disease Association as12 years. The focusing of the research and
well as additional resources from private anddevelopment team was one of the toughest
philanthropic organizations. Scientists are gainingchallenges in medicine: keeping Alzheimer's disease
insights how the disease progresses in the brain.from slowly, relentlessly destroying the brain. The
Many Experts believe that a new generation ofgoal was something no drug has yet done.
treatments will evolve that will prevent, slow orThere are also tests being conducted on a drug
perhaps reverse the damaging effects of Alzheimer'sderived from a Chinese moss that has been used for
disease.more than 2,000 years in the Middle Kingdom to treat
The newest discovery in the Alzheimer's researchfevers. Dr. Aisen, a leading researcher for Neurochem
community is from the UK. A team of researchlearned in 1999 that doctors in China had been using
scientist led by Dr. Emma Kidd at Cardiff University'sthe drug, called Huperzine A, for 20 years to relieve
Welsh School of Pharmacy recently completed asymptoms of Alzheimer's disease.
study showing that it is possible to decreaseThis drug is now made by Neuro-Hitech Inc. The drug
production of a small protein called amyloid (A*), Thisimproves memory in much the same way as Pfizer's
protein is believed to be the main cause of theAricept and other Alzheimer's treatments. However
disease. The research was funded by the Alzheimer'sthis natural derivative does not have the
Society, the UK's leading care and research charitygastrointestinal side effects. Aisen was most intrigued
for Alzheimer's disease and other types of dementia.by evidence that during research with mice,
Researchers at the University of California, LosHuperzine-A protected brain cells from the ravages
Angeles have discovered a new brain imagingof plaque and tangles. No other drug has been able
compound that shows promise by giving researchersto accomplish that feat.
a way to detect Alzheimer's disease earlier. ThisOver 12 million people worldwide suffer from
imaging molecule can detect and map the plaques andAlzheimer's disease. The direct and indirect cost of
tangles in the brains of people with Alzheimer'scaring for Alzheimer's victims in the United States
disease.alone is more than $100 billion a year. Research to
This discovery could eventually lead to earlierfind a cure for this dreaded disease is on-going. Some
diagnosis of the devastating disease. The compoundof the most promising information suggests that
is called FDDNP. FDDNP also holds promise as astrategies for maintaining a healthy lifestyle may help
research tool to evaluate new treatments forreduce the risks of developing this disease.
Alzheimer's. The study was funded in part by the